Catalent Pharma Solutions,, has introduced the Peel-ID label, a new product for clinical supply labeling that helps to reduce the risk of patients receiving the incorrect medication at clinical sites.

The patent-pending clinical label comprises a permanent portion, and a peel-off label containing the patient kit identifier, which can be removed by site personnel and affixed elsewhere on the patient kit to better facilitate storage, inventory management, and quick retrieval. Peel-ID labels are designed and printed in-house by Catalent and are available in a variety of standard sizes and designs to fit most patient kits.

The Peel-ID label was developed in response to some sites manually writing kit identification numbers on an unlabeled side of a package because the label is obscured due to the way the kits are stored. With a Peel-ID label, the risk of human error resulting from the incorrect kit being pulled from inventory due to illegible handwriting or incorrectly transposed numbers is greatly reduced, according to the company.

Source: Catalent Pharma Solutions